| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Benevich Eric is a Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $8.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 28, 2025 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 5,970 | $151.74 | $905,880.64 | -11.7% | -14.1% | - | |
| Feb 13, 2025 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 2,154 | $116.73 | $251,427.64 | -2.4% | +1.6% | +6.2% | |
| Feb 10, 2025 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 980 | $118.31 | $115,940.37 | -2.2% | +1.4% | +15.9% | |
| Jan 31, 2025 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 1,207 | $152.94 | $184,598.58 | -2.8% | -29.8% | -10.4% | |
| Apr 15, 2024 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 19,818 | $133.36 | $2,643,019.64 | -19.5% | +11.9% | -27.0% | |
| Mar 14, 2024 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 75,000 | $139.38 | $10,453,417.50 | -47.9% | -3.3% | -20.4% | |
| Feb 28, 2024 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 75,000 | $134.69 | $10,101,607.50 | -48.0% | +4.3% | -12.7% | |
| Feb 13, 2024 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 1,098 | $133.01 | $146,050.36 | -2.6% | +1.7% | -12.4% | |
| Feb 8, 2024 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 2,260 | $138.68 | $313,418.67 | -2.8% | +3.4% | -8.8% | |
| Jan 31, 2024 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 1,207 | $140.78 | $169,926.77 | -3.1% | -1.6% | +9.7% |